Cargando…
Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19
Autores principales: | Zhang, Da‐Wei, Li, Fang, Wei, Yuan‐Yuan, Hu, Lei, Chen, Su‐Hong, Yang, Ming‐Ming, Zhang, Wen‐Ting, Fei, Guang‐He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242253/ https://www.ncbi.nlm.nih.gov/pubmed/37278129 http://dx.doi.org/10.1002/ctm2.1294 |
Ejemplares similares
-
Risk factors for severe COVID-19: Evidence from 167 hospitalized patients in Anhui, China
por: Wei, Yuan-Yuan, et al.
Publicado: (2020) -
A 12‐genus bacterial signature identifies a group of severe autistic children with differential sensory behavior and brain structures
por: Shi, Kai, et al.
Publicado: (2021) -
Differential Characteristics of Patients for Hospitalized Severe COVID-19 Infected by the Omicron Variants and Wild Type of SARS-CoV-2 in China
por: Wei, Yuan-Yuan, et al.
Publicado: (2023) -
Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma
por: Liang, Lei, et al.
Publicado: (2021) -
Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
por: Liu, Zeming, et al.
Publicado: (2020)